ライフサイエンスコーパス: bullous keratopathy

1 ter graft survival in eyes with pseudophakic bullous keratopathy.

2 formed for Fuchs' dystrophy and pseudophakic bullous keratopathy.

3 secondary corneal edema due to pseudophakic bullous keratopathy.

4 y was also assessed within a rabbit model of bullous keratopathy.

5 p is strongest in patients with pseudophakic bullous keratopathy.

6 from Fuchs endothelial dystrophy and 5 with bullous keratopathy.

7 Fuchs endothelial dystrophy or pseudophakic bullous keratopathy.

8 of cellular adhesion molecules is altered in bullous keratopathy.

9 tes the dominant features of contemporaneous bullous keratopathy.

10 lay a significant role in the progression of bullous keratopathy.

11 nderwent DSAEK procedure due to pseudophakic bullous keratopathy.

12 tial relief to patients who develop it after bullous keratopathy.

13 sive endothelial cell loss, and pseudophakic bullous keratopathy.

14 or Fuchs endothelial dystrophy (260 eyes) or bullous keratopathy (15 eyes).

15 5 DMEK cases were performed for pseudophakic bullous keratopathy (2 cases, 1 in each cohort), and the

16 ns for DMEK included 7 cases of pseudophakic bullous keratopathy, 2 cases of failed DMEK, and 1 case

17 lial corneal dystrophy (32.5%), pseudophakic bullous keratopathy (35%), previous failed graft (27.5%)

18 Clinical outcomes of 23 DMEK procedures for bullous keratopathy (52%), failed previous transplant (3

19 captured by tear lipocalin from corneas with bullous keratopathy and dry eye.

20 erformed on eight cases each of pseudophakic bullous keratopathy and healthy corneas.

21 ctory of cornea in a patient presenting with bullous keratopathy and stinging symptoms.

22 o be effective in symptomatic improvement of bullous keratopathy, and infectious keratitis but furthe

23 ycans from human corneas with chronic edema, bullous keratopathy, and keratoconus and from normal cor

24 st, Africa, and South America), pseudophakic bullous keratopathy/aphakic bullous keratopathy (North A

25 glaucoma surgery, and prior graft failure or bullous keratopathy as surgical indication.

26 the most common indication for PTK is still bullous keratopathy, as PTK can be successfully used whi

27 Fuchs endothelial dystrophy or pseudophakic bullous keratopathy at a single tertiary center.

28 primary surgical indication was pseudophakic bullous keratopathy at a single tertiary center.

29 PK) for Fuchs endothelial dystrophy (FED) or bullous keratopathy (BK) in Asian eyes.

30 dystrophy (FECD) subgroup, and 27.4% of the bullous keratopathy (BK) subgroup did not show visual im

31 dothelial corneal dystrophy (FECD; 85.3%) or bullous keratopathy (BK; 10.5%).

32 dothelial corneal dystrophy (FECD; n = 314), bullous keratopathy (BK; n = 31), and failed previous en

33 dothelial corneal dystrophy [FECD]: n = 111; bullous keratopathy [BK]: n = 24; and failed graft: n =

34 he hypothesis that epithelial alterations in bullous keratopathy compromise the surface of the cornea

35 DNA damage was not detected in pseudophakic bullous keratopathy corneas, whereas it colocalized with

36 Fuchs endothelial dystrophy and pseudophakic bullous keratopathy, EK achieved better average best-cor

37 In our study of eyes with bullous keratopathy, endothelial keratoplasty under a pr

38 In contrast, none of the bullous keratopathy eyes showed any improvement througho

39 Fuchs endothelial dystrophy or pseudophakic bullous keratopathy from January 2006 through December 2

40 failed graft (HR 2.07, 95% CI 1.84-2.32) or bullous keratopathy (HR 1.47, 95% CI 1.33-1.61) vs Fuchs

41 mpared with normal controls and pseudophakic bullous keratopathy (iatrogenic CE cell loss) specimens.

42 uchs' endothelial dystrophy and pseudophakic bullous keratopathy in patients without other vision-lim

43 MEK surgery in the treatment of pseudophakic bullous keratopathy in the presence of sf-IOL and if-IOL

44 ssociated with Fuchs' endothelial dystrophy, bullous keratopathy, iridocorneal endothelial syndrome o

45 Pseudophakic bullous keratopathy manifests an abnormal corneal ocular

46 s endothelial corneal dystrophy (n = 28) and bullous keratopathy (n = 11).

47 SAEK graft failure (n = 3), and pseudophakic bullous keratopathy (n = 2).

48 gery (n = 127; 90%) followed by pseudophakic bullous keratopathy (n = 4; 4%) and regrafts (n = 9; 6.4

49 clude Fuchs endothelial dystrophy (n = 209), bullous keratopathy (n = 88), and previous graft failure

50 e traumatic globe rupture (six eyes, 27.3%), bullous keratopathy (nine eyes, 40.1%), failed previous

51 a), pseudophakic bullous keratopathy/aphakic bullous keratopathy (North America), and keratitis (Asia

52 mes than penetrating grafts for pseudophakic bullous keratopathy (P <0.001).

53 Fuchs endothelial dystrophy or pseudophakic bullous keratopathy (PBK) at a single institution.

54 FED and pseudophakic bullous keratopathy (PBK) corneal buttons were removed d

55 ched normal autopsy corneas and pseudophakic bullous keratopathy (PBK) corneas.

56 elial dystrophy and 9 eyes with pseudophakic bullous keratopathy (PBK) that underwent DSAEK, and 17 e

57 ication for DMEK was pseudophakic or aphakic bullous keratopathy (PBK), followed by graft failure and

58 hs endothelial dystrophy (FED), pseudophakic bullous keratopathy (PBK), infection and other indicatio

59 hs endothelial dystrophy (FED), pseudophakic bullous keratopathy (PBK), or keratoconus who had underg

60 For optical grafts, pseudophakic bullous keratopathy, postinfectious corneal scarring and

61 ld patient, using bandage contact lenses for bullous keratopathy, presented with redness, mild pain a

62 ly a Descemet membrane disorder), but not in bullous keratopathy (primarily an endothelial depletion)

63 was strongest in patients with pseudophakic bullous keratopathy (r = -0.62 [P = .01]).

64 ll and superficial cell layers were lower in bullous keratopathy specimens (1.6 vs. 2.0; P < 0.0001)

65 ers evident in sections was increased in the bullous keratopathy specimens compared with controls (0.

66 orated with antibodies to MUC16 was lower in bullous keratopathy specimens than in controls (0.5 vs.

67 In eyes with pseudophakic bullous keratopathy, the EndoGlide group had a superior

68 Fuchs endothelial dystrophy and pseudophakic bullous keratopathy undergoing DSAEK surgery were includ

69 monstrated in a pre-clinical rabbit model of bullous keratopathy using a tissue-engineered endothelia

70 s associated with them, such as pseudophakic bullous keratopathy, uveitis-glaucoma-hyphema syndrome,

71 EK failure in pseudophakic bullous keratopathy was associated with center experienc

72 The reduction of layers expressing MUC1 in bullous keratopathy was not statistically significant.

73 rformed for Fuchs' dystrophy or pseudophakic bullous keratopathy was poorer than survival of penetrat

74 Fuchs' endothelial dystrophy or pseudophakic bullous keratopathy were randomized to DMEK or UT-DSAEK

75 Fuchs endothelial dystrophy or pseudophakic bullous keratopathy who were considered good candidates

76 Fuchs endothelial dystrophy or pseudophakic bullous keratopathy who were good candidates for DMEK or

77 Fuchs endothelial dystrophy or pseudophakic bullous keratopathy with or without cataract.